Review




Structured Review

Ophidion Inc occt-htt sirna
Drugs for PolyQ diseases in commercial preclinical development
Occt Htt Sirna, supplied by Ophidion Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/occt-htt+sirna/occt+htt+sirna/pmc11311141-115-0-14
Average 90 stars, based on 1 article reviews
occt-htt sirna - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration"

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration

Journal: ACS Chemical Neuroscience

doi: 10.1021/acschemneuro.4c00184

Drugs for PolyQ diseases in commercial preclinical development
Figure Legend Snippet: Drugs for PolyQ diseases in commercial preclinical development

Techniques Used: Gene Expression, Derivative Assay, Ubiquitin Proteomics, CRISPR, shRNA, Inhibition, Functional Assay, Plasmid Preparation, Transmission Assay, Zinc-Fingers, Mutagenesis

Related Articles

Gene Expression:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Derivative Assay:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Ubiquitin Proteomics:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

CRISPR:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

shRNA:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Inhibition:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Functional Assay:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Plasmid Preparation:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Transmission Assay:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Zinc-Fingers:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Mutagenesis:

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.



Similar Products

90
Ophidion Inc occt-htt sirna
Drugs for PolyQ diseases in commercial preclinical development
Occt Htt Sirna, supplied by Ophidion Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/occt-htt+sirna/occt+htt+sirna/pmc11311141-115-0-14
Average 90 stars, based on 1 article reviews
occt-htt sirna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Drugs for PolyQ diseases in commercial preclinical development

Journal: ACS Chemical Neuroscience

Article Title: Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration

doi: 10.1021/acschemneuro.4c00184

Figure Lengend Snippet: Drugs for PolyQ diseases in commercial preclinical development

Article Snippet: OCCT-HTT siRNA , RNA interference , Gene expression inhibitor; HTT inhibitor , HD , Ophidion, USA.

Techniques: Gene Expression, Derivative Assay, Ubiquitin Proteomics, CRISPR, shRNA, Inhibition, Functional Assay, Plasmid Preparation, Transmission Assay, Zinc-Fingers, Mutagenesis